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always  tried  to  rebut  (rightly  or  wrongly)  only  what  they
truly  meant.
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Relationship between
dyspnea/oxygen saturation and leg
discomfort/6-minute walking
distance in patients with COPD
participating in pulmonary
rehabilitation
Dear  Editor,
Chronic  and  progressive  dyspnea,  the  most  characteristic
symptom  of  chronic  obstructive  pulmonary  disease  (COPD),
is  often  associated  with  physical  activity  reduction,  not  only
because  of  the  symptom  itself  but  also  because  of  the  antic-
ipation  of  discomfort  caused  by  physical  exertion.1,2 Fatigue
is  also  one  of  the  main  symptoms,  described  as  the  second
most  prevalent.1,3 Therefore,  relief  of  these  symptoms  is
one  of  the  primary  goals  in  the  management  of  patients  with
COPD.2
It  is  known  that  FEV1 is  not  useful  in  predicting  dyspnea
and  some  studies  have  evaluated  the  relationship  between
dyspnea  and  dynamic  hyperinflation.1,4 Similarly,  despite
exercise-induced  oxygen  desaturation  being  observed  in
patients  with  COPD,  mostly  in  those  with  more  severe  dis-
ease  and  with  predominant  emphysema  phenotype,  the
underlying  mechanism  remains  poorly  understood.5 Also,
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imb  muscle  dysfunction  may  play  an  important  role  in  exer-
ise  limitation.3
As  far  as  we  know,  no  previous  study  has  evaluated  the
elationship  between  dyspnea  and  oxygen  saturation  (SpO2),
or  between  leg  discomfort  and  distance  walked.
The  aims  of  this  study  were  to  investigate  the  association
etween  dyspnea  and  SpO2, and  between  leg  discomfort  and
istance  walked  in  the  6-minute  walk  test  (6MWT),  as  well
s  the  impact  of  Pulmonary  Rehabilitation  (PR)  program  on
hese  variables.
This  was  a  longitudinal  retrospective  study  of  patients
ith  COPD  who  completed  an  outpatient  PR  program  dur-
ng  2016  at  Pulmonology  Department  of  Centro  Hospitalar
niversitário  Lisboa  Norte,  Portugal.  Subjects  attended  a
ulticomponent  PR  program  with  patient-tailored  ther-
pies,  8--16  weeks  long.  Those  with  ambulatory  oxygen
upplementation  maintained  it  during  the  6MWT  and  exer-
ise  training.
At  the  beginning  and  at  the  end  of  PR  program,  all
atients  underwent  6MWT.  The  variables  analyzed  were  the
egree  of  dyspnea  and  leg  discomfort  at  the  end  of  eachUsing  software  SPSS ,  Wilcoxon  or  Students´  T-test  were
arried  out,  as  appropriate,  for  comparison  of  variables  at
he  beginning  and  at  the  end  of  the  program.  Associations
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Table  1  Baseline  characteristics  of  the  subjects.
Characteristics  Results
Male  n  (%) 37  (80.4)
Age (mean  in  years  ±  SD)  68  ±  10
BMI (mean  in  kg/m2 ±  SD)  25.7  ±  4.9
Current/former  smoker  n  (%)  44  (95.7)
Comorbidities
Arterial hypertension  n  (%)  29  (63)
Sleep obstructive  apnea  n  (%)  9  (20)
Bronchiectasis  n  (%)  9  (20)
Anxiety/depression  n  (%) 9  (20)
Atrial fibrillation  n  (%) 6  (13)
Structural heart  disease  n  (%) 6  (13)
Pulmonary  hypertension  n  (%)  5  (10.9)
Charlson Comorbidity  Index
(mean  ±  SD)  3.9  ±  1.5
GOLD airflow  limitation  severity
GOLD  1  n  (%)  4  (8.7)
GOLD 2  n  (%)  16  (34.8)
GOLD 3  n  (%)  19  (41.3)
GOLD 4  n  (%)  7  (15.2)
GOLD ABCD
GOLD  B  n  (%)  22  (47.8)
GOLD D  n  (%)  24  (52.2)
FEV1 post  BD  (mean  in  %  ±  SD)  48.7  ±  19.2
FVC post  BD  (mean  in  %  ±  SD)  83.4  ±  21.8
DLCO (mean  in  %  ±  SD)  48.6  ±  20
Respiratory failure
No respiratory  failure  n  (%)  4  (8.7)
Hypoxemic  n  (%)  34  (73.9)
Hypercapnic  n  (%)  8  (17.4)
Dyspnea
mMRC 2  n  (%)  30  (65.2)
mMRC 3  or  4  n  (%)  16  (34.8)
Legend: SD = standard deviation; BMI = body mass index; GOLD = Global Initiative Obstructive Lung Disease; FEV1 = forced expiratory vol-
ume in one second; BD = bronchodilator; FVC = forced vital capacity; DLCO = diffusing capacity: mMRC = modified Medical Research Council
Dyspnea Scale.
ere  assessed  using  Spearmans´  coefficient,  considering  sig-
ificant  p-values  below  0.05.
Forty-six  subjects  with  COPD  completed  the  PR  program,
hose  baseline  characteristics  are  summarized  in  Table  1.
hirty-seven  percent  of  them  were  on  long-term  oxygen
herapy  and  28.3%  were  on  nocturnal  noninvasive  ventila-
ion.
At  the  beginning  and  at  the  end  of  the  PR  program  the
ean  degree  of  dyspnea  was  3  ±  1.8  and  2.5  ±  1.7,  and
ean  minimum  SpO2 value  was  84.9  ±  5.4%  and  87.6  ±  4.3%,
espectively.  Only  SpO2 improved  significantly  (p  =  0.007)
Fig.  1A  and  1B).  We  observed  no  correlation  between  the
egree  of  dyspnea  and  minimum  SpO2, neither  in  the  initial
MWT  (p  =  0.31)  nor  in  the  final  one  (p  =  0.09).
median  value  of  2  ±  3  with  no  significant  improvement  after
PR  (p  =  0.128)  (Fig.  1D).  We  observed  a  mild  (rho  =  0.308)  but
significant  (p  =  0.04)  correlation  between  leg  discomfort  and
distance  walked  in  the  initial  6MWT,  but  not  in  the  final  one
(p  =  0.077).
This  study  shows  the  benefit  of  PR  programs  in  patients
with  COPD,  namely  in  oxygen  saturation  and  exercise  capac-
ity.  Similarly,  previous  studies  evidenced  improvement  in
arterial  oxygenation  with  breathing  techniques  such  as
pursed  lips  breathing  during  exercise  training,  with  physio-
logical  and  clinical  significance  indicating  its  possible  effect
in  decreasing  airway  collapse  and  respiratory  rate.6
The  multifactorial  nature  of  dyspnea  is  well  known  and
we  observed  no  correlation  between  the  degree  of  dysp-The  mean  distance  walked  was  340.7  ±  105  and
73.3  ±  95  m  in  the  initial  and  final  6MWT,  respectively,  with
ignificant  improvement  (p  =  0.003)  (Fig.  1C).  The  degree  of
eg  discomfort  reported  in  the  initial  and  final  6MWT  had  a
n
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nea  and  oxygen  saturation.  The  maintenance  of  dynamic
yperinflation,  airflow  limitation  and  respiratory  muscle
eakness,  leading  to  an  increased  mechanical  load  and  a
euromechanical  dissociation,  might  explain  in  part  this
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Figure  1  Boxplot  of  dyspnea  (A),  minimum  oxygen  saturation  (B),  distance  walked  (C)  and  leg  discomfort  (D)  in  the  6-minute
walk test  performed  at  the  beginning  and  at  the  end  of  pulmonary  rehabilitation  program.
absence  of  correlation  and  the  lack  of  significant  improve-
ment  in  dyspnea.1,4 Peripheral  muscle  dysfunction,  frequent
in  patients  with  COPD,  also  enhances  exertional  dyspnea
and  exercise  intolerance.2,3 Those  patients  often  have  an
augmented  lactic  acid  production  for  a  given  exercise  work
rate,  increasing  their  ventilatory  demand.2,3
After  PR  program,  our  subjects  reported  a  similar  degree
of  leg  discomfort  for  a  significantly  greater  distance  walked
(32.6  m).  This  is  in  line  with  extensive  evidence  showing
improvement  in  exercise  tolerance  with  a  significant  incre-
ment  in  distance  walked  by  patients  with  COPD  during  6MWT
after  PR  program.7
Our  findings  reflect  the  multifactorial  essence  of  dyspnea
and  fatigue  as  the  most  prevalent  characteristics  of  patients
with  COPD,  and  the  need  for  future  research  to  clarify  the
underlying  effects  of  PR  on  them.
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